Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Holly Attebury

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7965-2586; OpenAlex author ID A5019216830; NIH RePORTER profile ID 78348715. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
1
Labs led
0
Collaborators
10
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 grant · 2026: 1 paper

Papers 2

  1. Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization. Co-author DOI 10.1158/2159-8290.cd-25-0377↗
  2. The Gut Microbiome and Pancreatic Cancer Development and Treatment. Co-author DOI 10.1097/ppo.0000000000000647↗

Grants 1

  1. The role of bacterial dysbiosis and its influence on pancreatic cancer cell behavior F31CA306283↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Donnele Daley · 1 shared paper, 2023 · strength 0.39
  2. Brian D. Griffith · 1 shared paper, 2026 · strength 0.22
  3. Eileen S. Carpenter · 1 shared paper, 2026 · strength 0.22
  4. Padma Kadiyala · 1 shared paper, 2026 · strength 0.22
  5. Ahmed M. Elhossiny · 1 shared paper, 2026 · strength 0.22
  6. Marina Pasca di Magliano · 1 shared paper, 2026 · strength 0.22
  7. Katelyn L. Donahue · 1 shared paper, 2026 · strength 0.22
  8. Yaqing Zhang · 1 shared paper, 2026 · strength 0.22
  9. Timothy L. Frankel · 1 shared paper, 2026 · strength 0.22
  10. Filip Bednar · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.